Vitalliver

herbal suppository preparation of Radix Ginseng (Panax ginseng C.A. May), Cuscuta chinensis Lam, Fructus Cnidii (Cnidium monnier L. Cusson), Rhizoma Kaemferiae (Kaemferiae hainanensis Hayata) and Gekko gecko Linnaeus

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        Vitalliver: 1
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - Vitalliver: 1

Experts

1.	Chan, K: 1 article (08/2005)
2.	Chui, A K K: 1 article (08/2005)
3.	Chui, S H: 1 article (08/2005)
4.	Shek, L S L: 1 article (08/2005)
5.	Wong, R N S: 1 article (08/2005)

Related Diseases

1.	Infections 08/01/2005 - "The study investigated the regulatory effect of a Chinese herbal suppository, Vitalliver, on Hcy and IGF-1, as well as their relationship in patients with hepatitis B infection. " 08/01/2005 - "Forty patients with chronic hepatitis B virus (HBV) infection without cirrhosis, 25 males and 15 females, were observed for changes in Hcy and IGF-1 after the administration of Vitalliver (one nightly) for a period of 3 months. " 08/01/2005 - "The effects of a Chinese medicinal suppository (Vitalliver) on insulin-like growth factor 1 and homocysteine in patients with hepatitis B infection."
2.	Hepatitis B 08/01/2005 - "The study investigated the regulatory effect of a Chinese herbal suppository, Vitalliver, on Hcy and IGF-1, as well as their relationship in patients with hepatitis B infection. " 08/01/2005 - "The effects of a Chinese medicinal suppository (Vitalliver) on insulin-like growth factor 1 and homocysteine in patients with hepatitis B infection."
3.	Chronic Hepatitis B 08/01/2005 - "Forty patients with chronic hepatitis B virus (HBV) infection without cirrhosis, 25 males and 15 females, were observed for changes in Hcy and IGF-1 after the administration of Vitalliver (one nightly) for a period of 3 months. "
4.	Liver Cirrhosis (Hepatic Cirrhosis) 08/01/2005 - "In conclusion, it is speculated Vitalliver may have a self-regulatory effect on the release of IGF-1 in HBV patients without liver cirrhosis."
5.	Fibrosis (Cirrhosis) 08/01/2005 - "Forty patients with chronic hepatitis B virus (HBV) infection without cirrhosis, 25 males and 15 females, were observed for changes in Hcy and IGF-1 after the administration of Vitalliver (one nightly) for a period of 3 months. "

Related Drugs and Biologics

1.	Insulin-Like Growth Factor I (IGF-1)
2.	Homocysteine
3.	Insulin-Like Peptides